Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-11-28 Transaction in Own Shar…
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance references (e.g., ASX listing rules). The content is focused on the company's share repurchase activity rather than financial results, management changes, or other report types. The document length is over 5,000 characters and contains substantive data about the buy-back transactions. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2023-11-28 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and contains detailed information about the company's on-market share buy-back program, including daily updates on the number of securities bought back, prices paid, broker details, and dates. It is a daily buy-back notification rather than a full report or announcement of a new capital raising or share issue. The content matches the description of a Transaction in Own Shares (POS) filing, which reports the company's share repurchase activities. The document is over 5,000 characters and contains substantive data about the buy-back activity, not just an announcement or summary, so it is not an RPA or RNS. Therefore, the correct classification is POS.
2023-11-27 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification about a company's share buy-back activity, including daily updates on the number of securities bought back, prices paid, broker information, and regulatory compliance details. It specifically mentions 'Notification of buy-back' multiple times and provides daily buy-back statistics. This matches the description of a 'Transaction in Own Shares' filing, which reports the company's repurchase of its own shares. The document is not an announcement of a report, nor is it a financial report or management discussion. Therefore, the correct classification is 'POS' (Transaction in Own Shares). The document length and detail support a high confidence in this classification.
2023-11-26 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a daily buy-back of shares by Mayne Pharma Group Limited. It includes specifics such as the number of securities bought back, prices paid, dates, broker information, and regulatory compliance details related to the on-market buy-back program. The content is focused on the company's repurchase of its own shares and does not contain financial statements, earnings data, or other report types. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on share repurchase activities.
2023-11-23 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is a detailed notification of a buy-back program by Mayne Pharma Group Limited. It includes specifics such as the type of buy-back (on-market), dates, number of securities bought back, prices paid, broker information, and compliance with listing rules. The document is not a financial report or earnings release but a regulatory announcement about the company's share repurchase activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buy-back of its own shares.
2023-11-22 English
Update - Notification of buy-back - MYX 6 pages 27.7KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Notification of buy-back' and repeatedly references daily buy-back notifications, on-market buy-back details, and specific data about securities bought back, prices paid, and dates. It is an update announcement about the company's share repurchase activity. There is no indication of financial statements, management discussion, or other report content. The document is a regulatory announcement about the company's transaction in its own shares, specifically a buy-back program. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length and detail confirm it is not a brief report publication announcement or a simple regulatory filing. Confidence is high due to clear and repeated references to buy-back specifics and no conflicting content.
2023-11-21 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.